The Patient Typology about deprescribing and medication-related decisions: A quantitative exploration.

Weir, Kristie Rebecca; Scherer, Aaron M; Vordenberg, Sarah E; Streit, Sven; Jansen, Jesse; Jungo, Katharina Tabea (2024). The Patient Typology about deprescribing and medication-related decisions: A quantitative exploration. Basic clinical pharmacology and toxicology, 134(1), pp. 39-50. Wiley 10.1111/bcpt.13911

Preview	Text Weir_BasicClinPharmacolToxicol_2024.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (481kB) | Preview
Preview	Text Basic_Clin_Pharma_Tox_-_2023_-_Weir_-_The_Patient_Typology_about_deprescribing_and_medication_related_decisions_A.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (1MB) | Preview

This study aimed to test the adequacy of a quantitative measure of our qualitatively-developed Patient Typology - categories of older adults' attitudes towards medicines and medicine decision-making - and identify characteristics associated with each Typology. We conducted secondary data analyses of a subset of survey item measures of adults (≥65 years) who were members of online survey panels in Australia, the UK, the US, and the Netherlands (n=4,688). Multinomial logistic regression analyses assessed associations between demographic, psychosocial, and medication-related measures. Mean age was 71.5 (5) and 47.5% of participants were female. Factors associated with an increased likelihood of identifying with Typology 1 'Attached to medicines' over Typology 2 'Open to deprescribing' were higher positive attitude towards polypharmacy (RRR=1.12, p =<.001) and higher need for certainty (RRR=1.11, p=.039). Factors associated with an increased likelihood of identifying with Typology 3 'Defers (medication decision-making) to others' over Typology 2 were older age (RRR=1.47 per 10-year age increase, p=<.001) and a decreased likelihood of prior deprescribing experience (RRR=0.73, p=.033). This study provides validation of the Typology with large samples from four countries, with the quantitatively-measured typologies generally aligning with the qualitatively-derived categories. Our Patient Typology measure provides a succinct way researchers can assess attitudes towards deprescribing.

Interest & Impact

Downloads

22 since deposited on 12 Jun 2023
22 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item